rifaximin
A semisynthetic member of the class of rifamycins and non-systemic gastrointestinal site-specific broad spectrum antibiotic. Used in the treatment of traveller's diarrhoea, hepatic encephalopathy and irritable bowel syndrome.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
rifamycin antibioticARO:3000157
-
CHEBI:24995 -
CHEBI:26580 -
CHEBI:47622 -
CHEBI:51026 -
CHEBI:51914 -
CHEBI:59779 -
CHEBI:72588 - rifamycin antibiotic
ARO:3000157
Chemical structure
| Molecular formula | C43H51N3O11 |
|---|---|
| Charge | 0 |
| Average mass | 785.891 Da |
| Monoisotopic mass | 785.35236 Da |
| Source | ChEBI |
| InChIKey | NZCRJKRKKOLAOJ-XRCRFVBUSA-N |
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
InChI=1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/b12-11+,17-15+,21-13-/t20-,22+,23+,24+,27-,35-,36+,39+,43-/m0/s1
Also called
- Xifaxsan
- rifaximina
- rifaximine
- rifaximinun
- (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-25-yl acetate
- Rifamycin L 105
- Rifamycin L 105SV
- Rifaxidin
Cross-references
- rifaximin
ARO:3000517 - cas:80621-81-4
- hmdb:HMDB0015351
- reaxys:7790802
- chembl:CHEMBL1617
- pubchem.compound:6436173
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3000517 |
rifaximin | antibioticmech:aro-f950f96b1f |
2026-08-30 |
| CHEBI | CHEBI:75246 |
rifaximin | antibioticmech:chebi-ca0ee79f16 |
2026-08-30 |
Molecular targets
rifamycin sensitive beta-subunit of RNA polymerase (rpoB) PROTEIN_COMPLEX DIRECT_BINDING_TARGET
Mechanism summary
- Clinical status
- APPROVED
Resistance mechanisms
ANTIBIOTIC_INACTIVATION 6
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Streptomyces venezuelae rox | ARO:3007209 | — | ||
| iri | ARO:3002884 | — | ||
| rgt1438 | ARO:3002883 | — | ||
| rifampin ADP-ribosyltransferase (Arr) | ARO:3000390 | — | ||
| rphA | ARO:3000444 | — | ||
| rphB | ARO:3003992 | — |
ANTIBIOTIC_TARGET_REPLACEMENT 6
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Clostridioides difficile rpoB with mutation conferring resistance to rifampicin | ARO:3004563 | — | ||
| Escherichia coli rpoB mutants conferring resistance to rifampicin | ARO:3003288 | — | ||
| Mycobacterium leprae rpoB mutations conferring resistance to rifampicin | ARO:3003284 | — | ||
| Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin | ARO:3003283 | — | ||
| Staphylococcus aureus rpoB mutants conferring resistance to rifampicin | ARO:3003285 | — | ||
| rpoB2 | ARO:3000501 | — |
ANTIBIOTIC_TARGET_PROTECTION 4
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| DnaA | ARO:3000248 | — | ||
| HelR | ARO:3007208 | — | ||
| RbpA | ARO:3000245 | — | ||
| sigma factor conferring resistance to rifampin | ARO:3000261 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories